AGA Family of Websites:

Meet two digestive cancer researchers paving new paths

Get to know the two recipients of AGA’s digestive cancer research awards.
AGA 2022 Digestive Cancer Researchers
AGA 2022 Digestive Cancer Researchers

The AGA Research Foundation is proud to offer two specialty awards to investigators working on novel approaches in GI cancer research. Read about our 2022 recipients below.

Picture of Sarah Palmer Short, PhD

Sarah Palmer Short, PhD

Vanderbilt University Medical Center
Project: The role of glutathione peroxidase 1 in colorectal cancer development and progression 

Antioxident supplements touted as essential for good health may increase mortality rates among cancer patients. Dr. Short aims to mitigate risk by examining how antioxidant proteins contribute to colorectal cancer development, progression and chemotherapeutic response. Investigating the role of oxidative stress in the gut will inform how antioxidant therapy might modify disease development and treatment.  

Funding for this award is provided by an anonymous donor to the AGA Research Foundation Endowment Fund. 
Picture of Eunyoung Choi, PhD

Eunyoung Choi, PhD

Vanderbilt University Medical Center
Project: Oncogenic roles of Arid1a during gastric carcinogenesis 

Dr. Choi established novel and unique in vivo and in vitro model systems critical for understanding the carcinogenic process between dysplasia and adenocarcinoma. Her funded project will define the key functional and carcinogenic roles of a frequently mutated transcription factor, ARID1A, in gastric pre-cancer to cancer progression. Understanding the full spectrum of gastric carcinogenesis and identifying key factors responsible regulating for gastric dysplasia evolution will provide a pathway for early detection or prevention of gastric cancer. 

Support of this program by the R. Robert and Sally D. Funderburg Charitable Trust is gratefully acknowledged.
Made possible by the
AGA Research Foundation

AGA clinical guidance

Find the latest evidence-based recommendations for treating your patients.